Cargando…

Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment

Identifying the causes of high fever syndromes such as Kawasaki disease (KD) remains challenging. To investigate pathogen exposure signatures in suspected pathogen-mediated diseases such as KD, we performed immunoglobulin (Ig) profiling using a next-generation sequencing method. After intravenous Ig...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Tai-Ming, Kiyotani, Kazuma, Chang, Jeng-Sheng, Park, Jae-Hyun, Yin Yew, Poh, Chen, Yuan-Tsong, Wu, Jer-Yuarn, Nakamura, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048982/
https://www.ncbi.nlm.nih.gov/pubmed/29771320
http://dx.doi.org/10.1093/hmg/ddy176
_version_ 1783340201325625344
author Ko, Tai-Ming
Kiyotani, Kazuma
Chang, Jeng-Sheng
Park, Jae-Hyun
Yin Yew, Poh
Chen, Yuan-Tsong
Wu, Jer-Yuarn
Nakamura, Yusuke
author_facet Ko, Tai-Ming
Kiyotani, Kazuma
Chang, Jeng-Sheng
Park, Jae-Hyun
Yin Yew, Poh
Chen, Yuan-Tsong
Wu, Jer-Yuarn
Nakamura, Yusuke
author_sort Ko, Tai-Ming
collection PubMed
description Identifying the causes of high fever syndromes such as Kawasaki disease (KD) remains challenging. To investigate pathogen exposure signatures in suspected pathogen-mediated diseases such as KD, we performed immunoglobulin (Ig) profiling using a next-generation sequencing method. After intravenous Ig (IVIG) treatment, we observed disappearance of clonally expanded IgM clonotypes, which were dominantly observed in acute-phase patients. The complementary-determining region 3 (CDR3) sequences of dominant IgM clonotypes in acute-phase patients were commonly observed in other Ig isotypes. In acute-phase KD patients, we identified 32 unique IgM CDR3 clonotypes shared in three or more cases. Furthermore, before the IVIG treatment, the sums of dominant IgM clonotypes in IVIG-resistant KD patients were significantly higher than those of IVIG-sensitive KD patients. Collectively, we demonstrate a novel approach for identifying certain Ig clonotypes for potentially interacting with pathogens involved in KD; this approach could be applied for a wide variety of fever-causing diseases of unknown origin.
format Online
Article
Text
id pubmed-6048982
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-60489822018-07-20 Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment Ko, Tai-Ming Kiyotani, Kazuma Chang, Jeng-Sheng Park, Jae-Hyun Yin Yew, Poh Chen, Yuan-Tsong Wu, Jer-Yuarn Nakamura, Yusuke Hum Mol Genet Articles Identifying the causes of high fever syndromes such as Kawasaki disease (KD) remains challenging. To investigate pathogen exposure signatures in suspected pathogen-mediated diseases such as KD, we performed immunoglobulin (Ig) profiling using a next-generation sequencing method. After intravenous Ig (IVIG) treatment, we observed disappearance of clonally expanded IgM clonotypes, which were dominantly observed in acute-phase patients. The complementary-determining region 3 (CDR3) sequences of dominant IgM clonotypes in acute-phase patients were commonly observed in other Ig isotypes. In acute-phase KD patients, we identified 32 unique IgM CDR3 clonotypes shared in three or more cases. Furthermore, before the IVIG treatment, the sums of dominant IgM clonotypes in IVIG-resistant KD patients were significantly higher than those of IVIG-sensitive KD patients. Collectively, we demonstrate a novel approach for identifying certain Ig clonotypes for potentially interacting with pathogens involved in KD; this approach could be applied for a wide variety of fever-causing diseases of unknown origin. Oxford University Press 2018-08-01 2018-05-16 /pmc/articles/PMC6048982/ /pubmed/29771320 http://dx.doi.org/10.1093/hmg/ddy176 Text en © The Author(s) 2018. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Articles
Ko, Tai-Ming
Kiyotani, Kazuma
Chang, Jeng-Sheng
Park, Jae-Hyun
Yin Yew, Poh
Chen, Yuan-Tsong
Wu, Jer-Yuarn
Nakamura, Yusuke
Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment
title Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment
title_full Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment
title_fullStr Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment
title_full_unstemmed Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment
title_short Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment
title_sort immunoglobulin profiling identifies unique signatures in patients with kawasaki disease during intravenous immunoglobulin treatment
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048982/
https://www.ncbi.nlm.nih.gov/pubmed/29771320
http://dx.doi.org/10.1093/hmg/ddy176
work_keys_str_mv AT kotaiming immunoglobulinprofilingidentifiesuniquesignaturesinpatientswithkawasakidiseaseduringintravenousimmunoglobulintreatment
AT kiyotanikazuma immunoglobulinprofilingidentifiesuniquesignaturesinpatientswithkawasakidiseaseduringintravenousimmunoglobulintreatment
AT changjengsheng immunoglobulinprofilingidentifiesuniquesignaturesinpatientswithkawasakidiseaseduringintravenousimmunoglobulintreatment
AT parkjaehyun immunoglobulinprofilingidentifiesuniquesignaturesinpatientswithkawasakidiseaseduringintravenousimmunoglobulintreatment
AT yinyewpoh immunoglobulinprofilingidentifiesuniquesignaturesinpatientswithkawasakidiseaseduringintravenousimmunoglobulintreatment
AT chenyuantsong immunoglobulinprofilingidentifiesuniquesignaturesinpatientswithkawasakidiseaseduringintravenousimmunoglobulintreatment
AT wujeryuarn immunoglobulinprofilingidentifiesuniquesignaturesinpatientswithkawasakidiseaseduringintravenousimmunoglobulintreatment
AT nakamurayusuke immunoglobulinprofilingidentifiesuniquesignaturesinpatientswithkawasakidiseaseduringintravenousimmunoglobulintreatment